The results of prognosis reports indicate that OS with low expression of LATS2 is poor, which may be related to some aspects of the immune microenvironment in ESCC (Gajewski et al., 2006; Zheng et al., 2020). The gene discussed is LATS2; the disease is esophageal squamous cell carcinoma.